Note: Ingredients listed on restricted chemical lists
EC/CAS
265-159-2/64742-56-9
Name of the chemical
Distillates (petroleum), solvent-dewaxed light paraffinic
Concentration
≥90
EC/CAS
204-884-0/128-39-2
Name of the chemical
Phenol, 2,6-bis(1,1-dimethylethyl)
Concentration
<0.25
General Information
Version
3
Revision date
2019-11-19
Product name
Hyspin AWS 15
supplier name
BP France
Emergency telephone
Tél 01 45 42 59 59 : ORFILA
Icons in SDS
Company Information
company name
BP France
e-mail address of the competent person responsible for the Safety Data Sheet
MSDSadvice@bp.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]]
Product definition
Mixture
Signal word
Danger
Hazard statements
H304 - May be fatal if swallowed and enters airways.
Prevention
Not applicable.
Response
P301 + P310 + P331 - IF SWALLOWED: Immediately call a POISON CENTER or physician. Do NOT induce vomiting.
Storage
P405 - Store locked up.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
Distillates (petroleum), solvent-dewaxed light paraffinic
Supplemental label elements
Not applicable. elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
Results of PBT and vPvB assessment
Product does not meet the criteria for PBT or vPvB according to Regulation (EC) No. 1907/2006, Annex XIII. Product meets the criteria This mixture does not contain any substances that are assessed to be a PBT or a vPvB. for PBT or vPvB according to Regulation (EC) No.
Other hazards which do not result in classification
Defatting to the skin. Note: High Pressure Applications Injections through the skin resulting from contact with the product at high pressure constitute a major medical emergency. See 'Notes to physician' under First-Aid Measures, Section 4 of this Safety Data Sheet.
